SYSTEMIC LUPUS ERYTHEMATOSUS AND OPPORTUNISTIC INFECTIONS: PREVALENCE, CLINICAL FEATURES
https://doi.org/10.14412/1996-7012-2008-503
Abstract
Current therapy for systemic lupus erythematosus (SLE) envisages long-term treatment with cytostatic drugs, which is frequently accompanied by activation of comorbid infection, including viral one.
Objective: to determine the clinical features of SLE complicated by herpesviral infection.
Subjects and methods. Sixty-seven patients with a 1-to-7 history of SLE who received first-line therapy were examined. Results. The analysis of the history data and the results of a serological survey identified 3 groups of patients: 1) 35 patients with viral infection, of them 9 had mixed viral-and-bacterial infections; 2) 14 with bacterial infections and 3) 18 patients without viral-and-bacterial complications. The analysis of clinical symptoms established a correlation of high titers of antibodies to cytomegalovirus (CMV) and Epstein-Barr virus (EBV) with symptoms, such as fever, arthritis, lymphadenopathy, carditis, hepatomegaly and erythema migrans eruption. However, having the similar clinical manifestations, CMV and EBV infections had some organ specificity. In SLE, concomitant comorbid infection, viral infection in particular, contributed to the development of the clinical picture polymorphism with the protracted, remitting inflammatory process and the inadequate efficiency of glucocorticoid and immunosuppressive therapy.
Objective: to determine the clinical features of SLE complicated by herpesviral infection.
Subjects and methods. Sixty-seven patients with a 1-to-7 history of SLE who received first-line therapy were examined. Results. The analysis of the history data and the results of a serological survey identified 3 groups of patients: 1) 35 patients with viral infection, of them 9 had mixed viral-and-bacterial infections; 2) 14 with bacterial infections and 3) 18 patients without viral-and-bacterial complications. The analysis of clinical symptoms established a correlation of high titers of antibodies to cytomegalovirus (CMV) and Epstein-Barr virus (EBV) with symptoms, such as fever, arthritis, lymphadenopathy, carditis, hepatomegaly and erythema migrans eruption. However, having the similar clinical manifestations, CMV and EBV infections had some organ specificity. In SLE, concomitant comorbid infection, viral infection in particular, contributed to the development of the clinical picture polymorphism with the protracted, remitting inflammatory process and the inadequate efficiency of glucocorticoid and immunosuppressive therapy.
References
1. <div><p>Lu J.Y., Chen D.Y., Hsieh C.W. et al. Association of Epstein-Barr virus infection with systemic lupus erythematosus in Taiwan. Lupus 2007; 16: 168-75.</p><p>Клюквина Н.Г., Насонов Е.Л. Иммуно-супрессивная терапия системной красной волчанки: достоинства, недостатки и возможности совершенствования. РМЖ 2007; 15(8): 635-41.</p><p>Sekigawa I., Nawata M., Seta N. et al. Cytomegalovirus infection in patients with systemic lupus erythematosus. Clin Exp Rheum 2002; 20: 559-64.</p><p>Iliopoulus A.G., Tsokos G.C. Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Sem Arthr Rheum 1996; 25: 318-36.</p><p>Petri M. Infection in systemic lupus erythematosus.Rheum Dis Clin Am 1998; 24(2): 424-56.</p><p>Takei M., Yamakami K., Mitamura K. et al. A case of systemic lupus erythematosus complicated by alveolar hemorrhage and cytomegalovirus colitis. Clin Rheumatol 2007; 26(2): 274-7.</p><p>Shahnaz S., Choksi M.T., Tan I.J. Bilateral cytomegalovirus retinitis in a patient with systemic lupus erythematosus and end-stage renal disease. Mayo Clin Proc 2003; 78(11): 1412-5.</p><p>Исаков В.А., Архипова Е.И., Исаков Д.В. Герпесвирусные инфекции человека. СПб., 2006; 12-150.</p><p>Баринский И.Ф., Бикбулатова Р.М. Герпесвирусные инфекции (диагностика и лечение). М., 1990; 77-81.</p><p>Шахгильдян В.И. Цитомегаловирус-ная инфекция. Новый мед журнал 1997; 2: 2-6.</p><p>Kosminsky S., de Menezes R.C., Coеlho M.R. Epstein-Barr virus infection in patients with systemic lupus erythematosus. Rev Assoc Med Bras 2006; 52(5): 352-5.</p><p>Barzilai O., Sherer Y., Ram M. et al. Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report. Ann N Y Acad Sci 2007; 108: 67-77.</p><p>Tan E.M., Cohen A.S., Fries J.F. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum 1982; 25: 1271-7.</p><p>Егорова О.Н., Балабанова Р.М. Противовирусная терапия при ревматических заболеваниях. Фарматека 2007; 6: 90-4. David N Posnett and Dmitry Yarilin. Amplification of autoimmune disease by infection. Art Res Ther 2005; 7: 74-84.</p><p>Unanue E.R.Viral infections and nonspecific protection-good or bad? N Engl J Med 2007; 357(13): 1345-6.</p><p>Егорова О.Н., Балабанова Р.М., Чувиров Г.Н. Значение выявляемых при ревматологических заболеваниях антител к вирусам семейства Herpesviridae. Тер арх 1998; 5: 41-5.</p><p>Насонов Е.Л., Козлов Р.С., Якушин С.Б. Инфекционные осложнения терапии блокаторами фактора некроза опухоли: предупрежден - значит вооружен. Науч-практич ревматол 2007; 4 (при- лож): 38-48.</p><p>James J.A., Neas B.R., Moser K.L. et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthrit Rheum 2001; 44: 1122-6.</p><p>Kashiwagi Y., Kawashima H., Sato S. et al.Virological and immunological characteristics of fatal virus-associated haemophagocytic syndrome (VAHS). Microbiol Immunol 2007; 51(1): 53-62.</p><p>Chowdhary V.R., Grande J.P.,</p><p>Luthra H.S. et al.Characterization of haemorrhagic pulmonary capillaritis: another manifestation of Pristane-induced lupus. Rheumat (Oxford) 2007; 46(9): 1405-10.</p><p>Sato S., Kawashima H., Oshiro H. et al. Virological and immunological haracteristics of a 19-year-old Japanese female with fatal outcome with Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Virol 2004; 31(3): 235-8.</p><p>Kohn L.D., Kosugi S., Ban T. et al. Molecular basis for the autoreactivity against thyroid stimulating hormone receptor. Int Rev Immunol 1992; 9: 135-65.</p><p>Takei M., Yamakami K., Mitamura K. et al. A case of systemic lupus erythematosus complicated by alveolar hemorrhage and cytomegalovirus colitis. Clin Rheumatol 2007; 26(2): 274-7.</p><p>Hayashi T., Lee S., Ogasawara H. et al. Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection. Lupus 1998; 7(8): 561-4.</p></div><br />
Review
For citations:
Egorova ON, Balabanova RM, Sazhina EG, Egorova ON, Balabanova RM, Sazhina EG. SYSTEMIC LUPUS ERYTHEMATOSUS AND OPPORTUNISTIC INFECTIONS: PREVALENCE, CLINICAL FEATURES. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2008;2(4):27-33. (In Russ.) https://doi.org/10.14412/1996-7012-2008-503
Views:
1757
Email this article 